Organization
Sun Yat-Sen University Cancer Center, Guangdong, China
1 abstract
Abstract
Assessing therapeutic window and dose selection of ADG126 (a masked anti-CTLA-4 SAFEbody): Integrating nonclinical and clinical data using mathematical modeling.Org: Department of Clinical Medicine, Macquarie University, Sydney, Australia, One Clinical Research, Nedlands, Australia, Cabrini Research, Malvern, VIC, Australia, Sun Yat-Sen University Cancer Center, Guangdong, China, Adagene Inc., San Diego, CA,